Presence of AR-V7 correlated significantly with metastatic disease (p = 0.046), but not with other parameters classically associated with aggressive clinical course (i.e., initial PSA or Gleason score; p-range: 0.28-0.74; Table 3). Here, AR is linked to metastatic neoplasm.